PT1105102E - Composicao farmaceutica injectavel a base de um sal farmaceuticamente aceitavel do clopidogrel ou de ticlopidina - Google Patents
Composicao farmaceutica injectavel a base de um sal farmaceuticamente aceitavel do clopidogrel ou de ticlopidinaInfo
- Publication number
- PT1105102E PT1105102E PT99936748T PT99936748T PT1105102E PT 1105102 E PT1105102 E PT 1105102E PT 99936748 T PT99936748 T PT 99936748T PT 99936748 T PT99936748 T PT 99936748T PT 1105102 E PT1105102 E PT 1105102E
- Authority
- PT
- Portugal
- Prior art keywords
- clopidogrel
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable salt
- ticlopidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810567A FR2782455B3 (fr) | 1998-08-20 | 1998-08-20 | Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1105102E true PT1105102E (pt) | 2003-04-30 |
Family
ID=9529788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99936748T PT1105102E (pt) | 1998-08-20 | 1999-08-18 | Composicao farmaceutica injectavel a base de um sal farmaceuticamente aceitavel do clopidogrel ou de ticlopidina |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1105102B8 (pt) |
AT (1) | ATE230258T1 (pt) |
AU (1) | AU5173699A (pt) |
DE (1) | DE69904727T2 (pt) |
DK (1) | DK1105102T3 (pt) |
ES (1) | ES2189456T3 (pt) |
FR (1) | FR2782455B3 (pt) |
PT (1) | PT1105102E (pt) |
WO (1) | WO2000010534A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
US6413537B1 (en) | 2000-03-10 | 2002-07-02 | Wisconsin Alumni Research Foundation | Nystatin formulation having reduced toxicity |
WO2004081016A1 (en) | 2003-03-12 | 2004-09-23 | Cadila Healthcare Limited | Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate |
ATE492292T2 (de) * | 2003-04-02 | 2011-01-15 | Ares Trading Sa | Flüssige oder gefriergetrocknete pharmazeutische zusammensetzung enthaltend fsh und/oder lh, das nichtionische tensid poloxamer 188 und ein antibakterielles mittel |
EP1638595B1 (en) | 2003-06-20 | 2013-03-20 | Ares Trading S.A. | Freeze-dried fsh / lh formulations |
DK1847259T3 (da) * | 2006-04-13 | 2010-04-12 | Riemser Specialty Production Gmbh | Polyxamerer som smøremiddel til farmaceutiske sammensætningen indeholdende thieno[3,2-c]pyridin-derivater |
GB0804242D0 (en) * | 2008-03-07 | 2008-04-16 | Rosemont Pharmaceuticals Ltd | Clopidogrel solution |
EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
WO2009133455A2 (en) * | 2008-05-01 | 2009-11-05 | Cadila Healthcare Limited | Pharmaceutical composition of clodipogrel |
FR2932387B1 (fr) | 2008-06-16 | 2010-09-17 | Cll Pharma | Composition orale contenant un agent anti-plaquettaire de la famille des thienopyridines sous forme de base. |
US8563574B2 (en) * | 2009-12-07 | 2013-10-22 | Academic Pharmaceuticals, Inc. | Parenteral formulation of clopidogrel |
WO2011101865A2 (en) | 2010-02-19 | 2011-08-25 | Cadila Healthcare Limited | Stable pharmaceutical compositions of clopidogrel for parenteral delivery |
US20230059869A1 (en) | 2021-08-03 | 2023-02-23 | Liqmeds Worldwide Limited | Oral pharmaceutical solution of clopidogrel |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59409088D1 (de) * | 1994-10-04 | 2000-02-24 | Lohmann Rudolf Lomapharm | Lösungen von Anthrachinonen zur parenteralen Applikation |
FR2733914B1 (fr) * | 1995-05-11 | 1997-08-01 | Sanofi Sa | Composition de liquide stable contenant de l'urate oxydase et composition lyophilisee pour sa preparation |
FR2740686B1 (fr) * | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
-
1998
- 1998-08-20 FR FR9810567A patent/FR2782455B3/fr not_active Expired - Lifetime
-
1999
- 1999-08-18 DE DE69904727T patent/DE69904727T2/de not_active Expired - Lifetime
- 1999-08-18 AT AT99936748T patent/ATE230258T1/de active
- 1999-08-18 PT PT99936748T patent/PT1105102E/pt unknown
- 1999-08-18 AU AU51736/99A patent/AU5173699A/en not_active Abandoned
- 1999-08-18 DK DK99936748T patent/DK1105102T3/da active
- 1999-08-18 ES ES99936748T patent/ES2189456T3/es not_active Expired - Lifetime
- 1999-08-18 EP EP99936748A patent/EP1105102B8/fr not_active Expired - Lifetime
- 1999-08-18 WO PCT/FR1999/002003 patent/WO2000010534A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1105102A1 (fr) | 2001-06-13 |
AU5173699A (en) | 2000-03-14 |
EP1105102B1 (fr) | 2003-01-02 |
DE69904727D1 (de) | 2003-02-06 |
FR2782455A1 (fr) | 2000-02-25 |
EP1105102B8 (fr) | 2003-08-06 |
DK1105102T3 (da) | 2003-04-22 |
DE69904727T2 (de) | 2003-11-13 |
ES2189456T3 (es) | 2003-07-01 |
ATE230258T1 (de) | 2003-01-15 |
WO2000010534A1 (fr) | 2000-03-02 |
FR2782455B3 (fr) | 2000-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1105102E (pt) | Composicao farmaceutica injectavel a base de um sal farmaceuticamente aceitavel do clopidogrel ou de ticlopidina | |
DE69924232D1 (de) | Stabilisierte insulin-zubereitungen | |
ATE250924T1 (de) | Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel | |
HUP0203451A2 (hu) | Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra | |
BR0213379A (pt) | Formulação resistente a derramamento de mascaramento de gosto | |
BRPI0407583A (pt) | solução oftálmica lìmpida e estável | |
EA200201254A1 (ru) | Высококонцентрированные стабильные растворы мелоксикама | |
ATE292453T1 (de) | Antivirale arznei | |
IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
ZA200208761B (en) | Pharmaceutical form of administration for peptides, methods for its production and use. | |
MXPA03005221A (es) | Composicion farmaceutica de dronedarona para administracion parenteral. | |
ATE378070T1 (de) | Zusammensetzung mit fulvestrant | |
FR12C0064I2 (fr) | Compositions pharmaceutiques injectables d'un derive d'anthracenedione avec action anti-tumorale | |
DK1268522T3 (da) | LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler | |
EP1283042A4 (en) | AQUEOUS FLUID PREPARATION | |
DK1152763T3 (da) | Anvendelse af desozypeganin til behandling af stofafhængighed | |
NO980785D0 (no) | Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene | |
CY1105624T1 (el) | Αντιγλαυκωματικο μεσο και χρηση αυτου | |
ATE208627T1 (de) | Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen | |
BR9911960B1 (pt) | composição medicamentosa autoadesiva, e, utilização da mesma. | |
BR0008241A (pt) | Utilização de fanquinona para a preparação deuma composição farmacêutica para o tratamentode enfraquecimento de memória e método detratamento | |
TH51174A (th) | สารประกอบชนิดใหม่ |